Literature DB >> 9500312

Assessment of risk of cancer after renal transplantation.

C G Newstead1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9500312     DOI： 10.1016/s0140-6736(98)22009-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Risks of gene therapy should be weighed against lack of alternatives for many diseases.

Authors:  Robert E MacLaren; Robin R Ali; Adrian J Thrasher
Journal:  BMJ       Date:  2005-04-02

2.  TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.

Authors:  Thomas B Thornley; Michael A Brehm; Thomas G Markees; Leonard D Shultz; John P Mordes; Raymond M Welsh; Aldo A Rossini; Dale L Greiner
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

3.  XIAP gene expression protects β-cells and human islets from apoptotic cell death.

Authors:  Hao Wu; Ravikiran Panakanti; Feng Li; Ram I Mahato
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

4.  Inhibitors of C5 complement enhance vaccinia virus oncolysis.

Authors:  D Magge; Z S Guo; M E O'Malley; L Francis; R Ravindranathan; D L Bartlett
Journal:  Cancer Gene Ther       Date:  2013-05-10       Impact factor: 5.987

Review 5.  Immunological ignorance of solid tumors.

Authors:  Adrian F Ochsenbein
Journal:  Springer Semin Immunopathol       Date:  2005-01-27

6.  Post-transplant diagnosis of hereditary leiomyomatosis and renal cell carcinoma syndrome in a kidney donor.

Authors:  Jonathan J Lee; Vinod E Nambudiri; Jean Henneberry; Allison R Larson; Molly Wanner
Journal:  Clin Kidney J       Date:  2014-10-30

7.  Gene therapy for inborn errors of liver metabolism: progress towards clinical applications.

Authors:  Nicola Brunetti-Pierri
Journal:  Ital J Pediatr       Date:  2008-11-18       Impact factor: 2.638

8.  Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures?

Authors:  Lennart Hardell; Mikael Eriksson
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

9.  Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.

Authors:  R Castello; R Borzone; S D'Aria; P Annunziata; P Piccolo; N Brunetti-Pierri
Journal:  Gene Ther       Date:  2015-12-24       Impact factor: 5.250
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.